Q/C Technologies, Inc.
QCLS- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001321834
No open-market purchases or sales by Q/C Technologies, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.87M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Q/C Technologies, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 43 | 50 | +7 |
| Shares | 3.90M | 4.06M | +159.8K (+4.1%) |
| Value | $4.49M | $6.98M | +$2.49M (+55.4%) |
New holders (13)
Institutions that held Q/C Technologies, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Parallel Advisors, LLC | 25,125 | $43.2K | 0.00% |
| Nwam LLC | 25,000 | $43.0K | 0.00% |
| Commonwealth Equity Services, LLC | 17,044 | $29.0K | 0.00% |
| CI Private Wealth, LLC | 15,000 | $25.8K | 0.00% |
| SeaCrest Wealth Management, LLC | 12,850 | $22.1K | 0.00% |
| Kestra Private Wealth Services, LLC | 12,100 | $20.8K | 0.00% |
| Sawtooth Solutions, LLC | 10,000 | $17.2K | 0.00% |
| FMR LLC | 1,000 | $1.72K | 0.00% |
| WR Wealth Planners, LLC | 1,000 | $1.72K | 0.00% |
| JPMorgan Chase & Co | 347 | $1.00K | 0.00% |
| Federation des caisses Desjardins du Quebec | 500 | $860 | 0.00% |
| Strategic Investment Solutions, Inc. | 200 | $344 | 0.00% |
| Northwestern Mutual Wealth Management Co | 74 | $127 | 0.00% |
Sold out (6)
Institutions that held Q/C Technologies, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Shay Capital LLC | 207,235 | $238.3K |
| Millennium Management LLC | 68,312 | $79.0K |
| International Assets Investment Management, LLC | 67,000 | $77.0K |
| Two Sigma Investments, LP | 30,084 | $34.6K |
| UBS Group AG | 7,312 | $8.41K |
| IFP Advisors, Inc | 2 | – |